Even though gyromitrin has not been tested in animal models in relation to ALS yet, these and other possible future findings that point to environmental risk factors for ALS must be carefully examined in animals in connection to the onset of TDP-43 pathology. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.